Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
An automatic rebalancing portfolio automatically adjusts holdings to preserve the intended allocation across assets.
16,473 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
When two tech giants renew a crucial chip deal, markets react fast. Discover how the Broadcom collaboration could sha...
When a legendary actor steps into the music world, it isn’t just a career shift—it’s a case study in how creative inc...
A tight group of U.S.-listed power chip stocks built around silicon carbide and GaN technologies are rallying as elec...
Rising mortgage rates change buyer behavior and put pressure on single-family demand. This guide explains how mortgag...
A cooler June CPI prints suggest inflation is cooling, potentially giving the Fed room to hold rates steady. Markets ...
Investors are buzzing about The Metals Company as a potential new source of critical minerals. This article weighs th...
As AI infrastructure spending stays robust, memory names SanDisk and Micron pursue starkly different paths. SanDisk l...
A major index reshuffle moved Apollo Global out of Russell Growth and into Russell Value. What does this mean for inv...
Global markets slide as tech shares drop on fading AI chip optimism. Analysts warn the downturn could spill into broa...
A dementia diagnosis reshapes retirement plans as custodial care bills far exceed medical costs and Medicare coverage...
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...